Here, we identify BRN2, a key transcription factor lying downstream of three melanoma-associated signaling pathways (WNT/β-catenin, MAPK, and PI3K), as a tumor suppressor that functions to regulate PTEN expression. The gene discussed is POU3F2; the disease is melanoma.